Davies, A.; Cinieri, S.; Dupoiron, D.; España Fernandez, S.; Leclerc, J.; Montesarchio, V.; Mystakidou, K.; Serna, J.; Tack, J.; on behalf of the NACASY Study Group.
A Prospective, Real-World, Multinational Study of Naloxegol for Patients with Cancer Pain Diagnosed with Opioid-Induced Constipation—The NACASY Study. Cancers 2022, 14, 1128.
https://doi.org/10.3390/cancers14051128
AMA Style
Davies A, Cinieri S, Dupoiron D, España Fernandez S, Leclerc J, Montesarchio V, Mystakidou K, Serna J, Tack J, on behalf of the NACASY Study Group.
A Prospective, Real-World, Multinational Study of Naloxegol for Patients with Cancer Pain Diagnosed with Opioid-Induced Constipation—The NACASY Study. Cancers. 2022; 14(5):1128.
https://doi.org/10.3390/cancers14051128
Chicago/Turabian Style
Davies, Andrew, Saverio Cinieri, Denis Dupoiron, Sofia España Fernandez, Johan Leclerc, Vincenzo Montesarchio, Kyriaki Mystakidou, Judith Serna, Jan Tack, and on behalf of the NACASY Study Group.
2022. "A Prospective, Real-World, Multinational Study of Naloxegol for Patients with Cancer Pain Diagnosed with Opioid-Induced Constipation—The NACASY Study" Cancers 14, no. 5: 1128.
https://doi.org/10.3390/cancers14051128
APA Style
Davies, A., Cinieri, S., Dupoiron, D., España Fernandez, S., Leclerc, J., Montesarchio, V., Mystakidou, K., Serna, J., Tack, J., & on behalf of the NACASY Study Group.
(2022). A Prospective, Real-World, Multinational Study of Naloxegol for Patients with Cancer Pain Diagnosed with Opioid-Induced Constipation—The NACASY Study. Cancers, 14(5), 1128.
https://doi.org/10.3390/cancers14051128
